| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Cancer Center and Division of Environmental Science, Columbia University, New York, New York 10032 [L-L. H., S-W. H., R. M. S.], and Graduate Institute of Clinical Medicine, National Taiwan University Hospital, Taiwan, Republic of China [D-S. C.]
Two monoclonal antibodies (6A10 and 12F5) were obtained after fusion of mouse P3X63-AG.8.653 myeloma cells with spleen cells isolated from BALB/c mice immunized with imidazole ring-opened aflatoxin B1 (AFB1)-DNA and characterized by competitive enzyme-linked immunosorbent assays. Both antibodies are highly specific for imidazole ring opened AFB1-DNA and show some cross-reactivity with AFB1-DNA and no cross-reactivity with 8,9-dihydro-8-(7-guanyl)-9-hydroxy-AFB1, AFB1 conjugated with bovine serum albumin, aflatoxin M1 conjugated with bovine serum albumin, AFB1, or aflatoxin G1. Antibody 6A10 was further characterized and showed no cross-reactivity with DNA modified by several other carcinogens. It could detect adducts with 4-fold higher sensitivity in highly modified DNA (2.5 adducts/100 nucleotides) than in low modified DNA (4 adducts/105 nucleotides). With low modified DNA the limit of sensitivity is 5 adducts/107 nucleotides. Antibody 6A10 reliably detected adducts formed in vivo in rats and mice treated with AFB1. In a pilot study, AFB1 adducts were detected in liver tissues from individuals living in areas with suspected exposure to AFB1. Monitoring adduct levels in human tissue may provide information not only on carcinogen exposure but also on the relationship among infection with hepatitis B virus, dietary exposure to aflatoxin B1, and liver cancer.
1 This work was supported by National Institute of Environmental Health Sciences Grant ESO 3881 and NIH Grant CA 21111.
2 To whom requests for reprints should be addressed, at Division of Environmental Sciences, Columbia University, 650 W. 168th Street, New York, NY 10032.
Received 5/25/88. Revised 8/ 9/88. Accepted 8/15/88.
This article has been cited by other articles:
![]() |
V. Preisler, W. J. Caspary, F. Hoppe, R. Hagen, and H. Stopper Aflatoxin B1-induced mitotic recombination in L5178Y mouse lymphoma cells Mutagenesis, January 1, 2000; 15(1): 91 - 97. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. Lunn, R. G. Langlois, L. L. Hsieh, C. L. Thompson, and D. A. Bell XRCC1 Polymorphisms: Effects on Aflatoxin B1-DNA Adducts and Glycophorin A Variant Frequency Cancer Res., June 1, 1999; 59(11): 2557 - 2561. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Cell Growth & Differentiation |